According to our new research study on "Non-Gelatin Empty Capsules Market Forecast to 2031 - Global Analysis - by Product, Application, End User, and Geography," the market is expected to grow from US$ 2.73 billion in 2024 to US$ 5.11 billion by 2031; it is estimated to record a CAGR of 9.5% from 2025-2031. Key factors driving the growth of the non-gelatin empty capsules market are the rising prevalence of chronic diseases, regulatory and ethical constraints on animal-derived gelatin capsules, and demand for plant-based, vegan, halal/kosher & clean-label products.

The scope of the non-gelatin empty capsules market report includes the assessment of the market performance in North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa. Asia Pacific is anticipated to register the fastest CAGR in the non-gelatin empty capsules market from 2025 to 2031. Increasing conscious about health, higher demand for dietary supplements, and a rising elderly population are some of the factors that are contributing to the increased use of capsule-based medicines, supporting the non-gelatin empty capsules market growth in the Asia Pacific. The regions pharmaceutical and nutraceutical industries, mainly in India, China, and Japan, are the major drivers of the market growth, which is caused by low production costs and attractive government initiatives. Consumers preferences and religious beliefs are leading to the production of more vegetarian and gelatin-free capsules, accelerating the growth of the Asia-Pacific non-gelatin empty capsules market in the near future. The technological innovations in capsule manufacturing and the growing focus on personalized medicine have, by a great margin, improved the production efficiency and opened up new possibilities in drug delivery systems, thus becoming a significant factor aiding the non-gelatin empty capsules market in the region.

The market growth is being facilitated by increased consumer spending on health, improvements in healthcare infrastructure, and better access to over-the-counter (OTC) products. Contract manufacturing organizations (CMOs) in the Asia Pacific region are turning to collaborations with global pharmaceutical companies, which is leading to an increase in production capacity and export potential. To sum up, regulatory reforms that aim to harmonize drug approval processes across the region have made it easier for new products to enter the market. As investments in healthcare infrastructure and local pharmaceutical and biopharmaceutical production continue to rise, China will be a major source of supply for domestic demands as well as export markets. The shift to non-gelatin capsules, like those made from hydroxypropyl methylcellulose (HPMC) and pullulan, is mainly a nutraceutical trend. By-Health and other local brands in Guangdong province are making vegetarian capsules for herbal extracts and supplements their common packaging to attract vegan consumers and obtain halal certifications to serve the Southeast Asian markets, further fueling the growth of the non-gelatin empty capsules market.

China is home to a large population, and the number of people over 60 years is steadily increasing; as the aging population gets bigger, the occurrence of chronic diseases (such as cardiovascular disease, diabetes, and arthritis) is going up. Older populations choose formats that are easier to swallow, better tolerated, or with sustained/controlled release-capsules are most often the ones that meet these requirements. Furthermore, the non-gelatin empty capsules market is accelerating with the Indias distinct cultural and religious aspects, catering to large vegetarian and Jain communities, that have been instrumental in the shift towards non-gelatin alternatives. More than 70% of Indians have a preference for plant-based products, thus companies like Medi-Caps Limited are investing in the production of HPMC capsules colored to look like traditional medicine to attract the consumers. Last year Nitta Gelatin India stated that capsules became the second most popular drug format approved by the FDA, with 13% of new approvals utilizing these for worldwide exports, bolstering the non-gelatin empty capsules market growth.

Improvements in technology have been a major factor in the production process, and South Korean companies have poured a lot of money into automation to be able to fulfill a higher demand. A new product, EMBOCAPS AP60, a sophisticated delayed-release acid-resistant capsule for more than 60 minutes without phthalates or shellacs, was introduced by Suheung Co., Ltd., a major domestic manufacturer, in May 2024. The innovation, which is specifically designed for pharmaceuticals such as antibiotic dosage, has facilitated patient compliance and made Suheung the main exporter, thereby enabling the global market to be supplied. Therefore, the factors mentioned above are promoting a favorable environment for the non-gelatin empty capsules market in the region.

QUALICAPS, CapsCanada, Sunil Healthcare Limited, ACG, Natural Capsules Limited, BrightCaps GmbH, Fuji Capsule Co. Ltd., Evonik Industries AG, Lonza Group AG, and Suheung Co. Ltd. are among the leading companies profiled in the non-gelatin empty capsules market report.

Based on product, the non-gelatin empty capsules market is bifurcated into hydroxypropyl methyl cellulose (HPMC) and pullulan. On the basis of application, the market is segmented into antibiotic and antibacterial drugs, vitamins and dietary supplements, antacids and anti-flatulent preparations, and others. By end user, the non-gelatin empty capsules market is categorized into the pharmaceutical industry, the nutraceutical industry, the cosmetics industry, and the research laboratories. Geographically, the non-gelatin empty capsules market is categorized into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East and Africa (Saudi Arabia, South Africa, the UAE, and the Rest of the Middle East and Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).

Contact Us
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com